Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
Status:
Completed
Trial end date:
2006-06-19
Target enrollment:
Participant gender:
Summary
The study will compare and evaluate the effects of long-term treatment of monotherapy with
rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of
glycemic control in patients with recently diagnosed type 2 diabetes mellitus.